nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—type 2 diabetes mellitus	0.208	1	CbGaD
Sucralfate—ALB—Gliclazide—type 2 diabetes mellitus	0.0842	0.204	CbGbCtD
Sucralfate—ALB—Repaglinide—type 2 diabetes mellitus	0.0792	0.192	CbGbCtD
Sucralfate—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0661	0.16	CbGbCtD
Sucralfate—ALB—Valsartan—type 2 diabetes mellitus	0.0584	0.142	CbGbCtD
Sucralfate—ALB—Nateglinide—type 2 diabetes mellitus	0.0543	0.132	CbGbCtD
Sucralfate—ALB—Glyburide—type 2 diabetes mellitus	0.0367	0.0889	CbGbCtD
Sucralfate—ALB—Losartan—type 2 diabetes mellitus	0.0335	0.0813	CbGbCtD
Sucralfate—EGF—corneal epithelium—type 2 diabetes mellitus	0.0325	0.301	CbGeAlD
Sucralfate—FGG—islet of Langerhans—type 2 diabetes mellitus	0.00701	0.0649	CbGeAlD
Sucralfate—EGF—endothelium—type 2 diabetes mellitus	0.00595	0.0551	CbGeAlD
Sucralfate—PGA5—kidney—type 2 diabetes mellitus	0.00564	0.0522	CbGeAlD
Sucralfate—FGG—pancreas—type 2 diabetes mellitus	0.00493	0.0456	CbGeAlD
Sucralfate—FGA—islet of Langerhans—type 2 diabetes mellitus	0.00463	0.0429	CbGeAlD
Sucralfate—Haemolysis—Losartan—type 2 diabetes mellitus	0.00394	0.0878	CcSEcCtD
Sucralfate—FGB—cardiovascular system—type 2 diabetes mellitus	0.00392	0.0362	CbGeAlD
Sucralfate—FGB—kidney—type 2 diabetes mellitus	0.00383	0.0355	CbGeAlD
Sucralfate—FGA—cardiovascular system—type 2 diabetes mellitus	0.00335	0.031	CbGeAlD
Sucralfate—FGA—kidney—type 2 diabetes mellitus	0.00328	0.0303	CbGeAlD
Sucralfate—FGA—pancreas—type 2 diabetes mellitus	0.00326	0.0301	CbGeAlD
Sucralfate—Lung disorder—Sitagliptin—type 2 diabetes mellitus	0.0032	0.0715	CcSEcCtD
Sucralfate—FGG—liver—type 2 diabetes mellitus	0.00314	0.029	CbGeAlD
Sucralfate—FGF2—islet of Langerhans—type 2 diabetes mellitus	0.00299	0.0276	CbGeAlD
Sucralfate—Hyponatraemia—Tolbutamide—type 2 diabetes mellitus	0.00294	0.0657	CcSEcCtD
Sucralfate—EGF—retina—type 2 diabetes mellitus	0.00289	0.0268	CbGeAlD
Sucralfate—EGF—nephron tubule—type 2 diabetes mellitus	0.00273	0.0252	CbGeAlD
Sucralfate—Hyponatraemia—Tolazamide—type 2 diabetes mellitus	0.00268	0.0597	CcSEcCtD
Sucralfate—Hyponatraemia—Chlorpropamide—type 2 diabetes mellitus	0.00268	0.0597	CcSEcCtD
Sucralfate—EGF—cardiovascular system—type 2 diabetes mellitus	0.00245	0.0226	CbGeAlD
Sucralfate—FGB—liver—type 2 diabetes mellitus	0.00242	0.0224	CbGeAlD
Sucralfate—EGF—kidney—type 2 diabetes mellitus	0.00239	0.0222	CbGeAlD
Sucralfate—EGF—pancreas—type 2 diabetes mellitus	0.00238	0.022	CbGeAlD
Sucralfate—EGF—cortex of kidney—type 2 diabetes mellitus	0.00233	0.0216	CbGeAlD
Sucralfate—FGA—liver—type 2 diabetes mellitus	0.00207	0.0192	CbGeAlD
Sucralfate—FGF2—adipose tissue—type 2 diabetes mellitus	0.0019	0.0176	CbGeAlD
Sucralfate—Hyponatraemia—Glipizide—type 2 diabetes mellitus	0.00178	0.0396	CcSEcCtD
Sucralfate—Hyponatraemia—Glimepiride—type 2 diabetes mellitus	0.00166	0.037	CcSEcCtD
Sucralfate—EGF—liver—type 2 diabetes mellitus	0.00151	0.014	CbGeAlD
Sucralfate—Hyponatraemia—Glyburide—type 2 diabetes mellitus	0.00137	0.0305	CcSEcCtD
Sucralfate—Infection—Linagliptin—type 2 diabetes mellitus	0.00129	0.0288	CcSEcCtD
Sucralfate—Oedema—Acarbose—type 2 diabetes mellitus	0.00126	0.0281	CcSEcCtD
Sucralfate—Hyponatraemia—Gliclazide—type 2 diabetes mellitus	0.00123	0.0274	CcSEcCtD
Sucralfate—Hyponatraemia—Valsartan—type 2 diabetes mellitus	0.00113	0.0252	CcSEcCtD
Sucralfate—Oedema—Repaglinide—type 2 diabetes mellitus	0.00105	0.0234	CcSEcCtD
Sucralfate—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.000993	0.0222	CcSEcCtD
Sucralfate—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000987	0.022	CcSEcCtD
Sucralfate—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	0.000969	0.0216	CcSEcCtD
Sucralfate—Hyponatraemia—Losartan—type 2 diabetes mellitus	0.000912	0.0204	CcSEcCtD
Sucralfate—Oedema—Glipizide—type 2 diabetes mellitus	0.00087	0.0194	CcSEcCtD
Sucralfate—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000833	0.0186	CcSEcCtD
Sucralfate—Infection—Pioglitazone—type 2 diabetes mellitus	0.000828	0.0185	CcSEcCtD
Sucralfate—Infection—Sitagliptin—type 2 diabetes mellitus	0.000804	0.0179	CcSEcCtD
Sucralfate—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.000782	0.0175	CcSEcCtD
Sucralfate—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000732	0.0163	CcSEcCtD
Sucralfate—Infection—Bromocriptine—type 2 diabetes mellitus	0.000727	0.0162	CcSEcCtD
Sucralfate—Oedema—Glyburide—type 2 diabetes mellitus	0.000669	0.0149	CcSEcCtD
Sucralfate—Infection—Gliclazide—type 2 diabetes mellitus	0.000597	0.0133	CcSEcCtD
Sucralfate—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000579	0.0129	CcSEcCtD
Sucralfate—Oedema—Valsartan—type 2 diabetes mellitus	0.000552	0.0123	CcSEcCtD
Sucralfate—Infection—Valsartan—type 2 diabetes mellitus	0.000549	0.0122	CcSEcCtD
Sucralfate—Oedema—Orlistat—type 2 diabetes mellitus	0.000546	0.0122	CcSEcCtD
Sucralfate—Infection—Orlistat—type 2 diabetes mellitus	0.000542	0.0121	CcSEcCtD
Sucralfate—ALB—liver—type 2 diabetes mellitus	0.000523	0.00484	CbGeAlD
Sucralfate—Oedema—Metformin—type 2 diabetes mellitus	0.000503	0.0112	CcSEcCtD
Sucralfate—Infection—Metformin—type 2 diabetes mellitus	0.0005	0.0111	CcSEcCtD
Sucralfate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000475	0.0106	CcSEcCtD
Sucralfate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000475	0.0106	CcSEcCtD
Sucralfate—Infection—Irbesartan—type 2 diabetes mellitus	0.000471	0.0105	CcSEcCtD
Sucralfate—Oedema—Losartan—type 2 diabetes mellitus	0.000447	0.00996	CcSEcCtD
Sucralfate—Infection—Losartan—type 2 diabetes mellitus	0.000444	0.0099	CcSEcCtD
Sucralfate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000431	0.00962	CcSEcCtD
Sucralfate—Oedema—Ramipril—type 2 diabetes mellitus	0.000383	0.00854	CcSEcCtD
Sucralfate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000375	0.00837	CcSEcCtD
Sucralfate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000353	0.00788	CcSEcCtD
Sucralfate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000303	0.00675	CcSEcCtD
Sucralfate—FGF2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.18e-05	5.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	1.17e-05	5.16e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-05	5.12e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-05	5.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.16e-05	5.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.15e-05	5.07e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.15e-05	5.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.15e-05	5.07e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	1.15e-05	5.05e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.14e-05	5.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—SRC—type 2 diabetes mellitus	1.14e-05	5e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HIF1A—type 2 diabetes mellitus	1.13e-05	4.97e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—type 2 diabetes mellitus	1.13e-05	4.97e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IRS2—type 2 diabetes mellitus	1.13e-05	4.96e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PRKCB—type 2 diabetes mellitus	1.13e-05	4.96e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.13e-05	4.96e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—NFKB1—type 2 diabetes mellitus	1.12e-05	4.94e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ICAM1—type 2 diabetes mellitus	1.12e-05	4.94e-05	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—type 2 diabetes mellitus	1.12e-05	4.91e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CALM1—type 2 diabetes mellitus	1.11e-05	4.87e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-05	4.87e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—type 2 diabetes mellitus	1.1e-05	4.86e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.09e-05	4.82e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.09e-05	4.82e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.09e-05	4.82e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.09e-05	4.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—SRC—type 2 diabetes mellitus	1.09e-05	4.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOA1—type 2 diabetes mellitus	1.09e-05	4.8e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.09e-05	4.79e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.09e-05	4.79e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-05	4.77e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-05	4.77e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.08e-05	4.74e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—type 2 diabetes mellitus	1.08e-05	4.73e-05	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.07e-05	4.72e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1.07e-05	4.71e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IRS1—type 2 diabetes mellitus	1.07e-05	4.69e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-05	4.65e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-05	4.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.05e-05	4.62e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.05e-05	4.62e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—SRC—type 2 diabetes mellitus	1.05e-05	4.61e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—INS—type 2 diabetes mellitus	1.04e-05	4.59e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—type 2 diabetes mellitus	1.04e-05	4.59e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.04e-05	4.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS2—type 2 diabetes mellitus	1.03e-05	4.53e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.03e-05	4.52e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.02e-05	4.5e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.01e-05	4.46e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.01e-05	4.44e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.01e-05	4.44e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.01e-05	4.44e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.01e-05	4.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CASP8—type 2 diabetes mellitus	1e-05	4.42e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AVP—type 2 diabetes mellitus	9.99e-06	4.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.99e-06	4.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—type 2 diabetes mellitus	9.97e-06	4.39e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.95e-06	4.38e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	9.92e-06	4.37e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	9.92e-06	4.36e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.9e-06	4.36e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.9e-06	4.35e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT2—type 2 diabetes mellitus	9.87e-06	4.34e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IRS1—type 2 diabetes mellitus	9.85e-06	4.33e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—UCP3—type 2 diabetes mellitus	9.75e-06	4.29e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	9.75e-06	4.29e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—UCP2—type 2 diabetes mellitus	9.75e-06	4.29e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.7e-06	4.27e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.69e-06	4.27e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.69e-06	4.27e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—SRC—type 2 diabetes mellitus	9.66e-06	4.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOB—type 2 diabetes mellitus	9.66e-06	4.25e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—type 2 diabetes mellitus	9.62e-06	4.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.62e-06	4.23e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.58e-06	4.22e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—type 2 diabetes mellitus	9.57e-06	4.21e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.5e-06	4.18e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.5e-06	4.18e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.5e-06	4.18e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.46e-06	4.16e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.43e-06	4.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—INS—type 2 diabetes mellitus	9.43e-06	4.15e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CD36—type 2 diabetes mellitus	9.42e-06	4.15e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.39e-06	4.13e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	9.3e-06	4.09e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.3e-06	4.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LPL—type 2 diabetes mellitus	9.22e-06	4.06e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—type 2 diabetes mellitus	9.17e-06	4.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PCK1—type 2 diabetes mellitus	9.17e-06	4.04e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.15e-06	4.03e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.15e-06	4.03e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT2—type 2 diabetes mellitus	9.11e-06	4.01e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.03e-06	3.97e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.03e-06	3.97e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.99e-06	3.96e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PIK3R1—type 2 diabetes mellitus	8.96e-06	3.94e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	8.94e-06	3.93e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.81e-06	3.88e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	8.7e-06	3.83e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—type 2 diabetes mellitus	8.68e-06	3.82e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—SERPINE1—type 2 diabetes mellitus	8.66e-06	3.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.65e-06	3.81e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—type 2 diabetes mellitus	8.64e-06	3.8e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2—type 2 diabetes mellitus	8.62e-06	3.79e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RELA—type 2 diabetes mellitus	8.61e-06	3.79e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	8.59e-06	3.78e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HK1—type 2 diabetes mellitus	8.59e-06	3.78e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.58e-06	3.77e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.5e-06	3.74e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—type 2 diabetes mellitus	8.47e-06	3.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—RELA—type 2 diabetes mellitus	8.43e-06	3.71e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.4e-06	3.7e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	8.34e-06	3.67e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—C3—type 2 diabetes mellitus	8.3e-06	3.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	8.29e-06	3.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LPA—type 2 diabetes mellitus	8.29e-06	3.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCKR—type 2 diabetes mellitus	8.29e-06	3.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	8.29e-06	3.65e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—type 2 diabetes mellitus	8.27e-06	3.64e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PIK3R1—type 2 diabetes mellitus	8.27e-06	3.64e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	8.22e-06	3.62e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—type 2 diabetes mellitus	8e-06	3.52e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	7.99e-06	3.52e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.98e-06	3.51e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	7.95e-06	3.5e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.92e-06	3.48e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.9e-06	3.48e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AGT—type 2 diabetes mellitus	7.89e-06	3.47e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	7.84e-06	3.45e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.77e-06	3.42e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.76e-06	3.41e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	7.75e-06	3.41e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LEP—type 2 diabetes mellitus	7.73e-06	3.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—type 2 diabetes mellitus	7.73e-06	3.4e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.72e-06	3.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—type 2 diabetes mellitus	7.66e-06	3.37e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.64e-06	3.36e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.58e-06	3.34e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.57e-06	3.33e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—type 2 diabetes mellitus	7.56e-06	3.33e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.48e-06	3.29e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—type 2 diabetes mellitus	7.46e-06	3.28e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	7.39e-06	3.25e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.34e-06	3.23e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—type 2 diabetes mellitus	7.3e-06	3.21e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—type 2 diabetes mellitus	7.3e-06	3.21e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.29e-06	3.21e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.26e-06	3.2e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.11e-06	3.13e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NFKB1—type 2 diabetes mellitus	7.11e-06	3.13e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—type 2 diabetes mellitus	7.07e-06	3.11e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—type 2 diabetes mellitus	7.05e-06	3.1e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	6.9e-06	3.04e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.89e-06	3.03e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.88e-06	3.03e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	6.87e-06	3.02e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	6.86e-06	3.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.79e-06	2.99e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SRC—type 2 diabetes mellitus	6.77e-06	2.98e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTR—type 2 diabetes mellitus	6.76e-06	2.97e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	6.76e-06	2.97e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.74e-06	2.97e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.74e-06	2.97e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	6.63e-06	2.92e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SRC—type 2 diabetes mellitus	6.62e-06	2.91e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—INS—type 2 diabetes mellitus	6.6e-06	2.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.59e-06	2.9e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.59e-06	2.9e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HBA1—type 2 diabetes mellitus	6.59e-06	2.9e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LIPC—type 2 diabetes mellitus	6.59e-06	2.9e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCK—type 2 diabetes mellitus	6.59e-06	2.9e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.55e-06	2.88e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.52e-06	2.87e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—type 2 diabetes mellitus	6.51e-06	2.86e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—type 2 diabetes mellitus	6.51e-06	2.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.5e-06	2.86e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.43e-06	2.83e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.39e-06	2.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.38e-06	2.81e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CETP—type 2 diabetes mellitus	6.36e-06	2.8e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	6.23e-06	2.74e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	6.23e-06	2.74e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—SRC—type 2 diabetes mellitus	6.12e-06	2.69e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.06e-06	2.67e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.05e-06	2.66e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—type 2 diabetes mellitus	6.01e-06	2.64e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.93e-06	2.61e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.91e-06	2.6e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.91e-06	2.6e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.91e-06	2.6e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—type 2 diabetes mellitus	5.81e-06	2.55e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.8e-06	2.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.79e-06	2.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.79e-06	2.55e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.75e-06	2.53e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.67e-06	2.49e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.63e-06	2.48e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.55e-06	2.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—type 2 diabetes mellitus	5.47e-06	2.41e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.45e-06	2.4e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.41e-06	2.38e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—type 2 diabetes mellitus	5.36e-06	2.36e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.34e-06	2.35e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.34e-06	2.35e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.21e-06	2.29e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.19e-06	2.28e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.12e-06	2.25e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.12e-06	2.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.92e-06	2.16e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.65e-06	2.04e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.61e-06	2.03e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.6e-06	2.02e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—type 2 diabetes mellitus	4.56e-06	2.01e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.49e-06	1.97e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—type 2 diabetes mellitus	4.46e-06	1.96e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.42e-06	1.94e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.42e-06	1.94e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.4e-06	1.93e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.34e-06	1.91e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.28e-06	1.88e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.21e-06	1.85e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.21e-06	1.85e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.17e-06	1.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—type 2 diabetes mellitus	4.12e-06	1.81e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.12e-06	1.81e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—type 2 diabetes mellitus	4.12e-06	1.81e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.1e-06	1.8e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—LPL—type 2 diabetes mellitus	4.02e-06	1.77e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.94e-06	1.73e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.92e-06	1.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.83e-06	1.68e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.82e-06	1.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—type 2 diabetes mellitus	3.8e-06	1.67e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.77e-06	1.66e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.75e-06	1.65e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.62e-06	1.59e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.55e-06	1.56e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.44e-06	1.51e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.38e-06	1.49e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.37e-06	1.48e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.33e-06	1.47e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.94e-06	1.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.89e-06	1.27e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—INS—type 2 diabetes mellitus	2.88e-06	1.27e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.86e-06	1.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.66e-06	1.17e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.53e-06	1.11e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.53e-06	1.11e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-06	1.02e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	5.11e-06	CbGpPWpGaD
